STOCK TITAN

SCYNEXIS (SCYX) director receives new stock and option awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

SCYNEXIS director David C. Hastings received new equity awards as part of his compensation. He was granted 2,875 shares of common stock and a stock option for 2,875 shares at an exercise price of $3.85 per share. Both the restricted stock units and the option vest 100% on the first anniversary of the June 26, 2026 grant date, as long as he continues serving as a non-employee director. After the stock grant, he directly holds 11,522 common shares, and the new option expires on June 25, 2036. All amounts reflect a 1-for-8 reverse stock split effective May 29, 2026.

Positive

  • None.

Negative

  • None.
Insider HASTINGS DAVID C
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 2,875 $0.00 --
Grant/Award Common Stock 2,875 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 2,875 shares (Direct, null); Common Stock — 11,522 shares (Direct, null)
Footnotes (1)
  1. One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date. On May 29, 2026, the common stock of the Issuer underwent a 1-for-8 reverse stock split (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split. One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.
Restricted stock grant 2,875 shares Common stock granted to director on June 26, 2026
Stock option grant size 2,875 options Right to buy common stock granted June 26, 2026
Option exercise price $3.85 per share Exercise price for 2,875-share option grant
Shares held after grant 11,522 shares Total common shares directly owned after transaction
Option expiration date June 25, 2036 Expiration of 2,875-share stock option grant
Reverse stock split ratio 1-for-8 Common stock reverse split effective May 29, 2026
restricted stock unit financial
"shares subject to the restricted stock unit vest on the first anniversary"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
stock option financial
"shares subject to the option vest on the first anniversary of the date of grant"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"Stock Option (Right to Buy) with a conversion or exercise price of 3.8500"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
reverse stock split financial
"the common stock of the Issuer underwent a 1-for-8 reverse stock split"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HASTINGS DAVID C

(Last)(First)(Middle)
1 EVERTRUST PLAZA
13TH FLOOR

(Street)
JERSEY CITY NEW JERSEY 07302-6548

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
SCYNEXIS INC [ SCYX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/26/2026A2,875(1)A$0.0011,522(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$3.8506/26/2026A2,875 (3)06/25/2036Common Stock2,875$0.002,875D
Explanation of Responses:
1. One-hundred percent (100%) of the shares subject to the restricted stock unit vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.
2. On May 29, 2026, the common stock of the Issuer underwent a 1-for-8 reverse stock split (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split.
3. One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.
/s/ Robert F. Joyce Jr., by Power of Attorney06/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did SCYNEXIS (SCYX) director David C. Hastings report?

Director David C. Hastings reported receiving equity compensation awards, not buying on the open market. He was granted 2,875 shares of common stock and a stock option for 2,875 shares of SCYNEXIS common stock as part of his non-employee director compensation package.

How many SCYNEXIS (SCYX) shares did David C. Hastings receive in the latest Form 4?

David C. Hastings received 2,875 shares of SCYNEXIS common stock as a grant. These are restricted stock units that vest in full on the first anniversary of the June 26, 2026 grant date, provided he continues serving as a non-employee director on that vesting date.

What are the terms of David C. Hastings’ new SCYNEXIS (SCYX) stock options?

Hastings was granted a stock option covering 2,875 SCYNEXIS common shares at an exercise price of $3.85 per share. The option vests 100% on the first anniversary of the June 26, 2026 grant date and expires on June 25, 2036, assuming continuous director service.

How many SCYNEXIS (SCYX) shares does David C. Hastings own after this Form 4?

Following the reported grant, Hastings directly owns 11,522 shares of SCYNEXIS common stock. This figure reflects his holdings after receiving the 2,875-share restricted stock grant and incorporates the company’s previously effected 1-for-8 reverse stock split adjustments disclosed in the filing footnotes.

How do the SCYNEXIS (SCYX) equity awards to David C. Hastings vest?

Both the restricted stock units and the stock option granted to Hastings vest in a single tranche. One hundred percent of each award vests on the first anniversary of the June 26, 2026 grant date, provided he continues to provide services as a non-employee director through that vesting date.

What reverse stock split did SCYNEXIS (SCYX) disclose in this Form 4?

SCYNEXIS disclosed that on May 29, 2026, its common stock underwent a 1-for-8 reverse stock split. All share and option amounts reported for David C. Hastings in this Form 4 have been adjusted to reflect the effect of that reverse stock split on the company’s capital structure.